鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/31 | 3,140 | 3,195 | 3,135 | 3,135 | -20 | -0.6% | 28,300 |
| 2022/03/30 | 3,200 | 3,200 | 3,110 | 3,155 | -30 | -0.9% | 41,100 |
| 2022/03/29 | 3,195 | 3,200 | 3,150 | 3,185 | -20 | -0.6% | 41,300 |
| 2022/03/28 | 3,155 | 3,220 | 3,135 | 3,205 | +50 | +1.6% | 34,300 |
| 2022/03/25 | 3,125 | 3,185 | 3,125 | 3,155 | +30 | +1% | 23,900 |
| 2022/03/24 | 3,130 | 3,170 | 3,100 | 3,125 | -5 | -0.2% | 31,200 |
| 2022/03/23 | 3,085 | 3,145 | 3,065 | 3,130 | +85 | +2.8% | 32,900 |
| 2022/03/22 | 3,010 | 3,075 | 3,010 | 3,045 | +35 | +1.2% | 46,600 |
| 2022/03/18 | 2,934 | 3,015 | 2,922 | 3,010 | +95 | +3.3% | 59,500 |
| 2022/03/17 | 2,900 | 2,930 | 2,880 | 2,915 | +22 | +0.8% | 67,800 |
| 2022/03/16 | 2,898 | 2,916 | 2,882 | 2,893 | +13 | +0.5% | 62,500 |
| 2022/03/15 | 2,869 | 2,899 | 2,853 | 2,880 | +11 | +0.4% | 34,900 |
| 2022/03/14 | 2,850 | 2,899 | 2,850 | 2,869 | -14 | -0.5% | 31,700 |
| 2022/03/11 | 2,884 | 2,909 | 2,860 | 2,883 | -42 | -1.4% | 46,600 |
| 2022/03/10 | 2,929 | 2,940 | 2,885 | 2,925 | +64 | +2.2% | 76,400 |
| 2022/03/09 | 2,840 | 2,881 | 2,825 | 2,861 | +16 | +0.6% | 55,600 |
| 2022/03/08 | 2,853 | 2,902 | 2,823 | 2,845 | -51 | -1.8% | 65,300 |
| 2022/03/07 | 2,900 | 2,907 | 2,853 | 2,896 | -41 | -1.4% | 63,300 |
| 2022/03/04 | 2,921 | 2,982 | 2,902 | 2,937 | +12 | +0.4% | 75,100 |
| 2022/03/03 | 2,924 | 2,945 | 2,900 | 2,925 | +60 | +2.1% | 71,700 |
| 2022/03/02 | 2,918 | 2,944 | 2,865 | 2,865 | -77 | -2.6% | 41,600 |
| 2022/03/01 | 2,900 | 2,968 | 2,892 | 2,942 | +25 | +0.9% | 144,400 |
| 2022/02/28 | 2,944 | 2,944 | 2,892 | 2,917 | +17 | +0.6% | 99,900 |
| 2022/02/25 | 2,900 | 2,926 | 2,878 | 2,900 | +4 | +0.1% | 92,600 |
| 2022/02/24 | 2,900 | 2,910 | 2,845 | 2,896 | +12 | +0.4% | 81,700 |
| 2022/02/22 | 2,955 | 2,955 | 2,884 | 2,884 | -75 | -2.5% | 59,500 |
| 2022/02/21 | 2,983 | 3,015 | 2,926 | 2,959 | -25 | -0.8% | 57,200 |
| 2022/02/18 | 2,965 | 3,005 | 2,935 | 2,984 | +62 | +2.1% | 79,800 |
| 2022/02/17 | 2,938 | 3,035 | 2,907 | 2,922 | +34 | +1.2% | 92,800 |
| 2022/02/16 | 2,912 | 2,943 | 2,888 | 2,888 | +31 | +1.1% | 69,800 |
| 2022/02/15 | 2,839 | 2,887 | 2,820 | 2,857 | +23 | +0.8% | 151,300 |
| 2022/02/14 | 2,756 | 2,857 | 2,750 | 2,834 | -371 | -11.6% | 275,600 |
| 2022/02/10 | 3,190 | 3,235 | 3,145 | 3,205 | +35 | +1.1% | 111,700 |
| 2022/02/09 | 3,200 | 3,200 | 3,115 | 3,170 | +5 | +0.2% | 62,400 |
| 2022/02/08 | 3,200 | 3,220 | 3,155 | 3,165 | +25 | +0.8% | 42,800 |
| 2022/02/07 | 3,095 | 3,220 | 3,095 | 3,140 | +30 | +1% | 70,300 |
| 2022/02/04 | 3,050 | 3,150 | 3,030 | 3,110 | +80 | +2.6% | 116,000 |
| 2022/02/03 | 2,916 | 3,080 | 2,906 | 3,030 | +112 | +3.8% | 165,800 |
| 2022/02/02 | 2,854 | 2,925 | 2,830 | 2,918 | +79 | +2.8% | 57,400 |
| 2022/02/01 | 2,854 | 2,866 | 2,820 | 2,839 | -10 | -0.4% | 45,800 |
| 2022/01/31 | 2,848 | 2,863 | 2,814 | 2,849 | +7 | +0.2% | 31,000 |
| 2022/01/28 | 2,853 | 2,854 | 2,818 | 2,842 | +32 | +1.1% | 24,500 |
| 2022/01/27 | 2,887 | 2,887 | 2,776 | 2,810 | -63 | -2.2% | 46,600 |
| 2022/01/26 | 2,892 | 2,900 | 2,850 | 2,873 | -16 | -0.6% | 27,900 |
| 2022/01/25 | 2,907 | 2,938 | 2,859 | 2,889 | -18 | -0.6% | 63,000 |
| 2022/01/24 | 2,759 | 2,915 | 2,759 | 2,907 | +147 | +5.3% | 95,700 |
| 2022/01/21 | 2,731 | 2,761 | 2,694 | 2,760 | +29 | +1.1% | 35,200 |
| 2022/01/20 | 2,750 | 2,779 | 2,731 | 2,731 | +7 | +0.3% | 17,800 |
| 2022/01/19 | 2,775 | 2,775 | 2,708 | 2,724 | -96 | -3.4% | 47,800 |
| 2022/01/18 | 2,870 | 2,870 | 2,811 | 2,820 | -40 | -1.4% | 15,200 |
651～
700
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
